Dermatological Market Growth Opportunities and Forecast till 2030
CHAPTER 1. Industry Overview of Dermatological Market
1.1. Definition and Scope
1.1.1. Definition of Dermatological
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Dermatological Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Dermatological Market By Dermatological Disease
1.2.3. Dermatological Market By Drug Type
1.2.4. Dermatological Market By Route of Administration
1.2.5. Dermatological Market By Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Dermatological Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Dermatological Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Dermatological Market By Dermatological Disease
4.1. Introduction
4.2. Dermatological Market Revenue (USD Billion) By Dermatological Disease
4.2.1. Dermatological Market Revenue (USD Billion) and Forecast By Dermatological Disease, 2018-2030
4.2.2. Dermatitis
4.2.2.1. Dermatitis Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3. Acne
4.2.3.1. Acne Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.4. Skin Cancer
4.2.4.1. Skin Cancer Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.5. Psoriasis
4.2.5.1. Psoriasis Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.6. Rosacea
4.2.6.1. Rosacea Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.7. Alopecia
4.2.7.1. Alopecia Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 5. Dermatological Market By Drug Type
5.1. Introduction
5.2. Dermatological Market Revenue (USD Billion) By Drug Type
5.2.1. Dermatological Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
5.2.2. Prescription-Based Drugs
5.2.2.1. Prescription-Based Drugs Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Over-the-Counter Drugs
5.2.3.1. Over-the-Counter Drugs Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. Dermatological Market By Drug Type
6.1. Introduction
6.2. Dermatological Market Revenue (USD Billion) By Drug Type
6.2.1. Dermatological Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
6.2.2. Topical
6.2.2.1. Topical Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Oral
6.2.3.1. Oral Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.4. Parenteral Administration
6.2.4.1. Parenteral Administration Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. North America Dermatological Market By Country
7.1. North America Dermatological Market Overview
7.2. U.S.
7.2.1. U.S. Dermatological Market Revenue (USD Billion) and Forecast By Dermatological Disease, 2018-2030
7.2.2. U.S. Dermatological Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
7.2.3. U.S. Dermatological Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
7.3. Canada
7.3.1. Canada Dermatological Market Revenue (USD Billion) and Forecast By Dermatological Disease, 2018-2030
7.3.2. Canada Dermatological Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
7.3.3. Canada Dermatological Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
7.4. North America PEST Analysis
CHAPTER 8. Europe Dermatological Market By Country
8.1. Europe Dermatological Market Overview
8.2. U.K.
8.2.1. U.K. Dermatological Market Revenue (USD Billion) and Forecast By Dermatological Disease, 2018-2030
8.2.2. U.K. Dermatological Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
8.2.3. U.K. Dermatological Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
8.3. Germany
8.3.1. Germany Dermatological Market Revenue (USD Billion) and Forecast By Dermatological Disease, 2018-2030
8.3.2. Germany Dermatological Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
8.3.3. Germany Dermatological Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
8.4. France
8.4.1. France Dermatological Market Revenue (USD Billion) and Forecast By Dermatological Disease, 2018-2030
8.4.2. France Dermatological Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
8.4.3. France Dermatological Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
8.5. Spain
8.5.1. Spain Dermatological Market Revenue (USD Billion) and Forecast By Dermatological Disease, 2018-2030
8.5.2. Spain Dermatological Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
8.5.3. Spain Dermatological Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
8.6. Rest of Europe
8.6.1. Rest of Europe Dermatological Market Revenue (USD Billion) and Forecast By Dermatological Disease, 2018-2030
8.6.2. Rest of Europe Dermatological Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
8.6.3. Rest of Europe Dermatological Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Dermatological Market By Country
9.1. Asia Pacific Dermatological Market Overview
9.2. China
9.2.1. China Dermatological Market Revenue (USD Billion) and Forecast By Dermatological Disease, 2018-2030
9.2.2. China Dermatological Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
9.2.3. China Dermatological Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
9.3. Japan
9.3.1. Japan Dermatological Market Revenue (USD Billion) and Forecast By Dermatological Disease, 2018-2030
9.3.2. Japan Dermatological Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
9.3.3. Japan Dermatological Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
9.4. India
9.4.1. India Dermatological Market Revenue (USD Billion) and Forecast By Dermatological Disease, 2018-2030
9.4.2. India Dermatological Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
9.4.3. India Dermatological Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
9.5. Australia
9.5.1. Australia Dermatological Market Revenue (USD Billion) and Forecast By Dermatological Disease, 2018-2030
9.5.2. Australia Dermatological Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
9.5.3. Australia Dermatological Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
9.6. South Korea
9.6.1. South Korea Dermatological Market Revenue (USD Billion) and Forecast By Dermatological Disease, 2018-2030
9.6.2. South Korea Dermatological Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
9.6.3. South Korea Dermatological Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Dermatological Market Revenue (USD Billion) and Forecast By Dermatological Disease, 2018-2030
9.7.2. Rest of Asia-Pacific Dermatological Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
9.7.3. Rest of Asia-Pacific Dermatological Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Dermatological Market By Country
10.1. Latin America Dermatological Market Overview
10.2. Brazil
10.2.1. Brazil Dermatological Market Revenue (USD Billion) and Forecast By Dermatological Disease, 2018-2030
10.2.2. Brazil Dermatological Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
10.2.3. Brazil Dermatological Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
10.3. Mexico
10.3.1. Mexico Dermatological Market Revenue (USD Billion) and Forecast By Dermatological Disease, 2018-2030
10.3.2. Mexico Dermatological Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
10.3.3. Mexico Dermatological Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
10.4. Rest of Latin America
10.4.1. Rest of Latin America Dermatological Market Revenue (USD Billion) and Forecast By Dermatological Disease, 2018-2030
10.4.2. Rest of Latin America Dermatological Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
10.4.3. Rest of Latin America Dermatological Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
CHAPTER 11. Middle East & Africa Dermatological Market Overview
11.1. GCC
11.1.1. GCC Dermatological Market Revenue (USD Billion) and Forecast By Dermatological Disease, 2018-2030
11.1.2. GCC Dermatological Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
11.1.3. GCC Dermatological Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
11.2. South Africa
11.2.1. South Africa Dermatological Market Revenue (USD Billion) and Forecast By Dermatological Disease, 2018-2030
11.2.2. South Africa Dermatological Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
11.2.3. South Africa Dermatological Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
11.3. Rest of Middle East & Africa
11.3.1. Rest of Middle East & Africa Dermatological Market Revenue (USD Billion) and Forecast By Dermatological Disease, 2018-2030
11.3.2. Rest of Middle East & Africa Dermatological Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
11.3.3. Rest of Middle East & Africa Dermatological Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
11.4. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Dermatological Market
12.1. Dermatological Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investments
12.2.2. Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Dermatological market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements
CHAPTER 13. Company Profile
13.1. Merck KGaA
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Billion), 2021
13.1.3.2. Merck KGaA 2021 Dermatological Business Regional Analysis
13.1.4. Product / Service and Specification
13.1.5. Recent Developments & Business Strategy
13.1.6. Manufacturing Plant Footprint Analysis
13.2. Bayer AG
13.3. Johnson & Johnson
13.4. Novartis AG
13.5. GlaxoSmithKline plc
13.6. AstraZeneca
13.7. Galderma S.A.
13.8. Amgen Inc.
13.9. AbbVie Inc.
13.10. Pfizer Inc.